Works matching IS 11745878 AND DT 2024 AND VI 26 AND IP 4
Results: 10
Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges.
- Published in:
- Pediatric Drugs, 2024, v. 26, n. 4, p. 397, doi. 10.1007/s40272-024-00639-5
- By:
- Publication type:
- Article
Machine Learning: A Potential Therapeutic Tool to Facilitate Neonatal Therapeutic Decision Making.
- Published in:
- Pediatric Drugs, 2024, v. 26, n. 4, p. 355, doi. 10.1007/s40272-024-00638-6
- By:
- Publication type:
- Article
Alirocumab: Pediatric First Approval.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Inotuzumab Ozogamicin: First Pediatric Approval.
- Published in:
- Pediatric Drugs, 2024, v. 26, n. 4, p. 459, doi. 10.1007/s40272-024-00634-w
- By:
- Publication type:
- Article
Personalized Dosing of Medicines for Children: A Primer on Pediatric Pharmacometrics for Clinicians.
- Published in:
- Pediatric Drugs, 2024, v. 26, n. 4, p. 365, doi. 10.1007/s40272-024-00633-x
- By:
- Publication type:
- Article
Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An Update.
- Published in:
- Pediatric Drugs, 2024, v. 26, n. 4, p. 381, doi. 10.1007/s40272-024-00632-y
- By:
- Publication type:
- Article
Population Pharmacokinetics of Adalimumab in Juvenile Idiopathic Arthritis Patients: A Retrospective Cohort Study Using Clinical Care Data.
- Published in:
- Pediatric Drugs, 2024, v. 26, n. 4, p. 441, doi. 10.1007/s40272-024-00629-7
- By:
- Publication type:
- Article
A Pilot Study of Ketotifen in Patients Aged 8–17 Years with Functional Dyspepsia Associated with Mucosal Eosinophilia.
- Published in:
- Pediatric Drugs, 2024, v. 26, n. 4, p. 451, doi. 10.1007/s40272-024-00628-8
- By:
- Publication type:
- Article
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus.
- Published in:
- Pediatric Drugs, 2024, v. 26, n. 4, p. 411, doi. 10.1007/s40272-024-00625-x
- By:
- Publication type:
- Article
Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors.
- Published in:
- Pediatric Drugs, 2024, v. 26, n. 4, p. 429, doi. 10.1007/s40272-024-00624-y
- By:
- Publication type:
- Article